Entity Details

Primary name CXG2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ5T442
EntryNameCXG2_HUMAN
FullNameGap junction gamma-2 protein
TaxID9606
Evidenceevidence at protein level
Length439
SequenceStatuscomplete
DateCreated2005-11-08
DateModified2021-06-02

Ontological Relatives

GenesGJC2

GO terms

Show/Hide Table
GOName
GO:0001932 regulation of protein phosphorylation
GO:0005243 gap junction channel activity
GO:0005921 gap junction
GO:0005922 connexin complex
GO:0007267 cell-cell signaling
GO:0007420 brain development
GO:0009636 response to toxic substance
GO:0010628 positive regulation of gene expression
GO:0010644 cell communication by electrical coupling
GO:0016021 integral component of membrane
GO:0033270 paranode region of axon
GO:0043204 perikaryon
GO:0043209 myelin sheath
GO:0070447 positive regulation of oligodendrocyte progenitor proliferation
GO:1903763 gap junction channel activity involved in cell communication by electrical coupling
GO:1904427 positive regulation of calcium ion transmembrane transport
GO:1990769 proximal neuron projection
GO:2000134 negative regulation of G1/S transition of mitotic cell cycle

Subcellular Location

Show/Hide Table
Subcellular Location
Cell junction
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000500 ConnexinFamilyFamily
IPR013092 Connexin, N-terminalDomainDomain
IPR017990 Connexin, conserved siteSiteConserved site
IPR019570 Gap junction protein, cysteine-rich domainDomainDomain
IPR038359 Connexin, N-terminal domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613480 OMIMLymphatic malformation 3 (LMPHM3)A form of primary lymphedema, a disease characterized by swelling of body parts due to developmental anomalies and functional defects of the lymphatic system. Patients with lymphedema may suffer from recurrent local infections. LMPHM3 is an autosomal dominant form with variable severity and reduced penetrance. Affected individuals manifest lymphedema of the lower limbs and some patients have lymphedema of the hands. The disease is caused by variants affecting the gene represented in this entry.
613206 OMIMSpastic paraplegia 44, autosomal recessive (SPG44)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. The disease is caused by variants affecting the gene represented in this entry.
608804 OMIMLeukodystrophy, hypomyelinating, 2 (HLD2)An autosomal recessive hypomyelinating leukodystrophy with symptoms of Pelizaeus-Merzbacher disease. Clinically characterized by nystagmus, impaired motor development, ataxia, choreoathetotic movements, dysarthria, and progressive spasticity. The disease is caused by variants affecting the gene represented in this entry.

Interactions

6 interactions